Press releases
- Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
- Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
- Fulgent Reports First Quarter 2024 Financial Results
- Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Key statistics
On Monday, Fulgent Genetics Inc (FLGT*:MEX) closed at 376.43, 9.11% above its 52-week low of 345.01, set on May 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | 361.62 |
Previous close | 353.41 |
Average volume | 0.00 |
---|---|
Shares outstanding | 29.92m |
Free float | 20.18m |
P/E (TTM) | -- |
Market cap | 617.94m USD |
EPS (TTM) | -5.57 USD |
Data delayed at least 20 minutes, as of May 13 2024 17:51 BST.
More ▼